Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives

Bioorganic Chemistry
Fida HussainAbdul Sadiq

Abstract

α-Glucosidase is considered as a therapeutic target for the treatment of type 2 diabetes mellitus (DM2). In current study, we synthesized pyrrolidine-2,5-dione (succinimide) and thiazolidine-2,4-dione derivatives and evaluated for their ability to inhibit α-Glucosidase. Pyrrolidine-2,5-dione derivatives (11a-o) showed moderate to poor α-glucosidase inhibition. Compound 11o with the IC50 value of 28.3 ± 0.28 µM emerged as a good inhibitor of α-glucosidase. Thiazolidine-2,4-dione and dihydropyrimidine (TZD-DHPM) hybrids (22a-c) showed excellent inhibitory activities. The most active compound 22a displayed IC50 value of 0.98 ± 0.008 µM. Other two compounds of this series also showed activity in low micromolar range. The in-vivo antidiabetic study of three compounds 11n, 11o and 22a were also determined using alloxan induced diabetes mice model. Compounds 11o and 22a showed significant hypoglycemic effect compared to the reference drug. In-vivo acute toxicity study showed the safety of these selected compounds. In-silico docking studies were carried out to rationalize the in-vitro results. The binding modes and bioassay results of TZD-DHPM hybrids showed that interactions with important residues appeared significant for high potency.

References

Dec 1, 2000·The Annals of Pharmacotherapy·L K CampbellR K Campbell
Sep 11, 2004·Bioorganic & Medicinal Chemistry Letters·Jin Hee AhnSung Soo Kim
Feb 7, 2006·Current Medicinal Chemistry·Xiaolong ChenYinchu Shen
May 17, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Rhona M JackDeeksha Bali
Jul 1, 2009·Diabetes Care·Abbas E KitabchiJoseph N Fisher
Jul 23, 2009·Chemical Society Reviews·Shu-Li YouMi Zeng
Feb 26, 2010·Mediators of Inflammation·Hideaki KanetoTaka-aki Matsuoka
Jul 9, 2010·Chemical Reviews·Anton V GulevichValentine G Nenajdenko
May 23, 2012·Nature·Tony Scully
Jan 1, 2012·Journal of Community Hospital Internal Medicine Perspectives·Celeste C L Quianzon, Issam E Cheikh
Jan 9, 2014·Bioorganic & Medicinal Chemistry·Madiha Sahar KhanMisbahul Ain Khan
Jun 5, 2014·BMC Complementary and Alternative Medicine·Syed Muhammad Mukarram ShahFarhat Ullah
May 1, 2014·Diabetes Spectrum : a Publication of the American Diabetes Association·John R White
Aug 16, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Imoh S Okon, Ming-Hui Zou
Aug 27, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Laura Flores-BocanegraRachel Mata
Mar 28, 2016·European Journal of Medicinal Chemistry·Umer RashidNaveeda Akhter Qureshi
May 13, 2017·ChemMedChem·Zhiyang Liu, Shutao Ma
Dec 10, 2017·Chemistry Central Journal· SuchetaPrabhakar Kumar Verma
Jan 27, 2018·Cell Death & Disease·Caroline Maria Oliveira VolpeJosé Augusto Nogueira-Machado
Feb 1, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nguyen Van QuanRolf Teschke
Jul 13, 2019·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Nguyen Van QuanTran Dang Dat

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.